November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage ...

Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to an aggregate of $30.25 per share ...

The New Delhi blast and the Faridabad terror module indicate an uncomfortable time for India in terms of internal stability ...

Objectives To alleviate the shortage of qualified physicians in rural areas, since 2010, the Chinese government has launched a National Compulsory Service Programme (NCSP) to enrol medical students ...

Oh My God is – a guy who accidentally wins everything possible. Buys a token as a joke – gets a Lamborghini. Opens a mystery ...

Artificial intelligence has redefined what it means to measure and understand human intelligence. Once limited to ...

Generated record Q3 Contribution ex-TAC and programmatic revenue Renewed and expanded strategic ACR data and ad monetization partnership with ...

Very strong order momentum, with third quarter order intake up 33% year-over-yearOrder backlog increased by another 6% since June 2025, ...

Q3 Revenue of $29.0 Million;Net Income of $0.5 Million, an Improvement of $34.2 Million;Adjusted EBITDA of $4.1 Million, an Improvement of $4.7 Million;Extends Maturity of Senior Debt to 2028 LOS ANGE ...